SE411753B - Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid - Google Patents

Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid

Info

Publication number
SE411753B
SE411753B SE7502341A SE7502341A SE411753B SE 411753 B SE411753 B SE 411753B SE 7502341 A SE7502341 A SE 7502341A SE 7502341 A SE7502341 A SE 7502341A SE 411753 B SE411753 B SE 411753B
Authority
SE
Sweden
Prior art keywords
benzylpyrrolidinyl
benzamide
alkyl
procedure
therapeutically active
Prior art date
Application number
SE7502341A
Other languages
English (en)
Swedish (sv)
Other versions
SE7502341L (US20100056889A1-20100304-C00004.png
Inventor
G Bulteau
J Acher
J-C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7407535A external-priority patent/FR2262966A1/fr
Priority claimed from FR7503799A external-priority patent/FR2299862B1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of SE7502341L publication Critical patent/SE7502341L/xx
Publication of SE411753B publication Critical patent/SE411753B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7502341A 1974-03-05 1975-03-03 Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid SE411753B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7407535A FR2262966A1 (en) 1974-03-05 1974-03-05 N-(2-azacycloalkyl-alkyl)-benzamide derivs. - with antiemetic, antiulcer and CNS activity
FR7503799A FR2299862B1 (fr) 1975-02-07 1975-02-07 Nouveau

Publications (2)

Publication Number Publication Date
SE7502341L SE7502341L (US20100056889A1-20100304-C00004.png) 1975-09-08
SE411753B true SE411753B (sv) 1980-02-04

Family

ID=26218209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7502341A SE411753B (sv) 1974-03-05 1975-03-03 Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid

Country Status (29)

Country Link
US (1) US4029673A (US20100056889A1-20100304-C00004.png)
JP (1) JPS6058750B2 (US20100056889A1-20100304-C00004.png)
AR (1) AR212960A1 (US20100056889A1-20100304-C00004.png)
AT (1) AT350546B (US20100056889A1-20100304-C00004.png)
BG (1) BG25072A3 (US20100056889A1-20100304-C00004.png)
CA (1) CA1060029A (US20100056889A1-20100304-C00004.png)
CH (1) CH605793A5 (US20100056889A1-20100304-C00004.png)
CS (1) CS189691B2 (US20100056889A1-20100304-C00004.png)
DD (1) DD117451A5 (US20100056889A1-20100304-C00004.png)
DE (1) DE2508045C2 (US20100056889A1-20100304-C00004.png)
DK (1) DK145376C (US20100056889A1-20100304-C00004.png)
EG (1) EG11971A (US20100056889A1-20100304-C00004.png)
ES (1) ES435273A1 (US20100056889A1-20100304-C00004.png)
FI (1) FI58494C (US20100056889A1-20100304-C00004.png)
GB (1) GB1466646A (US20100056889A1-20100304-C00004.png)
HK (1) HK13978A (US20100056889A1-20100304-C00004.png)
HU (1) HU172091B (US20100056889A1-20100304-C00004.png)
IE (1) IE40860B1 (US20100056889A1-20100304-C00004.png)
IL (1) IL46695A (US20100056889A1-20100304-C00004.png)
LU (1) LU71948A1 (US20100056889A1-20100304-C00004.png)
NL (1) NL184617C (US20100056889A1-20100304-C00004.png)
NO (1) NO144740C (US20100056889A1-20100304-C00004.png)
OA (1) OA04967A (US20100056889A1-20100304-C00004.png)
PH (1) PH14207A (US20100056889A1-20100304-C00004.png)
PL (1) PL96942B1 (US20100056889A1-20100304-C00004.png)
RO (1) RO73247A (US20100056889A1-20100304-C00004.png)
SE (1) SE411753B (US20100056889A1-20100304-C00004.png)
SU (1) SU602116A3 (US20100056889A1-20100304-C00004.png)
YU (1) YU51775A (US20100056889A1-20100304-C00004.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189495A (en) * 1974-09-17 1980-02-19 Synthelabo 2-Methoxy-benzamide derivatives
US4172143A (en) * 1974-12-18 1979-10-23 Synthelabo 2-Methoxy-benzamide derivatives
US4158060A (en) * 1974-12-18 1979-06-12 Synthelabo 2-Methoxy-benzamide derivatives
US4163789A (en) * 1976-02-17 1979-08-07 Anphar, S.A. Anti-psychotic (cycloalkenylalkylpiperidino) benzamides
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
FR2386524A1 (fr) * 1977-04-05 1978-11-03 Choay Sa Amino-4 chloro-5 methoxy-2 n-(n-ethyl methyl-2 pyrrolidino)benzenesulfonamide, procede de preparation et medicaments le contenant
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
IT1095415B (it) * 1978-02-16 1985-08-10 Ravizza Spa Processo per la produzione di una benzamide otticamente attiva,benzamide otticamente attiva cosi'ottenuta e composizioni
SE411118B (sv) * 1978-03-23 1979-12-03 Astra Laekemedel Ab Ett forfarande for framstellning av 2,6-dialkoxibensamider med terapentiska egenskaper
US4263316A (en) * 1978-10-11 1981-04-21 Societe D'etudes Scientifiques Et Industrielles De L'ile De France N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl benzamide and its derivatives, methods of preparing them and their application to the treatment of troubles of the lower part of the body
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
FR2489327B1 (fr) * 1980-08-28 1984-05-18 Ile De France N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
JPS5970666A (ja) * 1982-10-15 1984-04-21 Kyowa Hakko Kogyo Co Ltd 1,4−ジヒドロピリジン誘導体
US5240957A (en) * 1984-01-31 1993-08-31 Astra Lakemedel Akteibolag Oxysalicylamido derivatives
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
JPS62174017A (ja) * 1986-08-29 1987-07-30 Kyowa Hakko Kogyo Co Ltd 1,4−ジヒドロピリジン誘導体
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
JP4113602B2 (ja) * 1997-04-04 2008-07-09 株式会社資生堂 ピロリジン誘導体及び抗潰瘍剤、抗菌剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
DE1785124A1 (de) * 1968-08-13 1971-11-11 Prym Werke William Reissverschluss
DE2327192C2 (de) * 1972-06-01 1983-02-17 Société d'Etudes Scientifiques et Industrielles de l'Ile-de-France S.A., 75340 Paris Verfahren zur Herstellung von N-(Diethylaminoethyl)-2-methoxy-5-methylsulfonylbenzamid und seinen Additionssalzen
US3923829A (en) * 1972-06-13 1975-12-02 Fratmann Ag Preparation of N-(1-ethyl-{60 -pyrrolidylmethyl)-2-methoxy-5-sulfonamidobenzamide
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds

Also Published As

Publication number Publication date
DK145376B (da) 1982-11-08
HK13978A (en) 1978-03-23
NL7502607A (nl) 1975-09-09
DK86875A (US20100056889A1-20100304-C00004.png) 1975-09-06
DE2508045C2 (de) 1986-11-06
LU71948A1 (US20100056889A1-20100304-C00004.png) 1976-02-04
RO73247A (ro) 1982-10-11
JPS50123667A (US20100056889A1-20100304-C00004.png) 1975-09-29
OA04967A (fr) 1980-10-31
DD117451A5 (US20100056889A1-20100304-C00004.png) 1976-01-12
CH605793A5 (US20100056889A1-20100304-C00004.png) 1978-10-13
US4029673A (en) 1977-06-14
NO144740B (no) 1981-07-20
PL96942B1 (pl) 1978-01-31
ATA160675A (de) 1978-11-15
IE40860B1 (en) 1979-08-29
FI58494C (fi) 1981-02-10
YU51775A (en) 1983-02-28
AT350546B (de) 1979-06-11
GB1466646A (en) 1977-03-09
DE2508045A1 (de) 1975-09-11
NO144740C (no) 1981-10-28
AU7868875A (en) 1976-09-02
BG25072A3 (en) 1978-07-12
HU172091B (hu) 1978-05-28
DK145376C (da) 1983-04-11
IL46695A0 (en) 1975-04-25
JPS6058750B2 (ja) 1985-12-21
IL46695A (en) 1979-01-31
CA1060029A (en) 1979-08-07
EG11971A (en) 1978-06-30
SU602116A3 (ru) 1978-04-05
CS189691B2 (en) 1979-04-30
PH14207A (en) 1981-04-02
FI750619A (US20100056889A1-20100304-C00004.png) 1975-09-06
FI58494B (fi) 1980-10-31
IE40860L (en) 1975-09-05
NO750714L (US20100056889A1-20100304-C00004.png) 1975-09-08
AR212960A1 (es) 1978-11-30
NL184617C (nl) 1989-09-18
SE7502341L (US20100056889A1-20100304-C00004.png) 1975-09-08
ES435273A1 (es) 1976-12-16

Similar Documents

Publication Publication Date Title
SE411753B (sv) Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid
SE430329B (sv) Forfarande for framstellning av nya terapeutiskt verksamma foreningar
SE7513571L (sv) Forfarande for framstellning av nya substituerade pyridiner
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
SE405598B (sv) Forfarande for framstellning av nya terapeutiskt verksamma derivat av 4-(3-amino-2-hydroxi-propoxi)-indol
SE390535B (sv) Forfarande att framstella terapeutiskt aktiva derivat av 3-(2-amino-propyl)-indol
NO810816L (no) Utgangsmateriale for fremstilling av terapeutisk aktive aminosyrederivater
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
SE411754B (sv) Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(2-pyrrolidinylalkyl)-bensamid
SE385583B (sv) Forfarande for framstellning av nya terapeutiskt aktiva derivat av isoindolin
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO137894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
SE394810B (sv) Analogiforfarande for framstellning av nya terapeutiskt aktiva derivat av dipeptider
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO139733C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
SE405356B (sv) Forfarande att framstella nya farmaceutiskt anvendbara derivat av 2-aminoalkyl-3-fenyl-isoindol
SE7504779L (sv) Forfarande for framstellning av nya isokinoliner
NO141608C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7502341-6

Effective date: 19931008

Format of ref document f/p: F